Selective inhibition of inducible nitric oxide synthase prevents ischaemicbrain injury

Citation
S. Parmentier et al., Selective inhibition of inducible nitric oxide synthase prevents ischaemicbrain injury, BR J PHARM, 127(2), 1999, pp. 546-552
Citations number
28
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BRITISH JOURNAL OF PHARMACOLOGY
ISSN journal
00071188 → ACNP
Volume
127
Issue
2
Year of publication
1999
Pages
546 - 552
Database
ISI
SICI code
0007-1188(199905)127:2<546:SIOINO>2.0.ZU;2-A
Abstract
1 The aim of this study was to investigate the effect of N-(3-(aminomethyl )benzyl)acetamidine (1400W), a selective inhibitor of inducible calcium-ind ependent nitric oxide synthase (iNOS), on the functional and histopathologi cal outcomes of experimental transient focal cerebral ischaemia in rats, 2 Transient ischaemia was produced by the occlusion for 2 h of both the lef t middle cerebral artery and common carotid artery. Treatments with 1400W ( 20 mg kg(-1)) or vehicle were started 18 h after occlusion of the arteries and consisted in seven subcutaneous injections at 8 h interval. Isc haemic outcomes and NOS activities (constitutive and calcium-independent NOS) were evaluated 3 days Lifter ischaemia. 3 1400W significantly reduced ischaemic lesion volume by 31%, and attenuate d weight loss and neurological dysfunction. 4 1400W attenuated the calcium-independent NOS activity in the infarct by 3 6% without affecting the constitutive NOS activity. 5 These findings suggest that iNOS activation contributes to tissue damage and that selective inhibitors of this isoform may be of interest for the tr eatment of stroke.